60 Degrees Pharmaceuticals (SXTP) Receivables (2022 - 2025)
Historic Receivables for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $674036.0.
- 60 Degrees Pharmaceuticals' Receivables rose 10815.02% to $674036.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $674036.0, marking a year-over-year increase of 10815.02%. This contributed to the annual value of $486748.0 for FY2024, which is 11041.1% up from last year.
- Per 60 Degrees Pharmaceuticals' latest filing, its Receivables stood at $674036.0 for Q3 2025, which was up 10815.02% from $295034.0 recorded in Q2 2025.
- 60 Degrees Pharmaceuticals' Receivables' 5-year high stood at $674036.0 during Q3 2025, with a 5-year trough of $45965.0 in Q4 2022.
- Moreover, its 4-year median value for Receivables was $296370.0 (2024), whereas its average is $311022.6.
- Per our database at Business Quant, 60 Degrees Pharmaceuticals' Receivables skyrocketed by 40327.86% in 2023 and then plummeted by 45.08% in 2025.
- Over the past 4 years, 60 Degrees Pharmaceuticals' Receivables (Quarter) stood at $45965.0 in 2022, then soared by 403.28% to $231332.0 in 2023, then soared by 110.41% to $486748.0 in 2024, then soared by 38.48% to $674036.0 in 2025.
- Its last three reported values are $674036.0 in Q3 2025, $295034.0 for Q2 2025, and $488243.0 during Q1 2025.